REPORT ID 697

EMEA (Europe, Middle East and Africa) Pressurized Metered-dose Inhaler Market Report 2017

Publish Date
01-Dec-17
Pages
103
Format
Electronic (PDF)

In this report, the EMEA Pressurized Metered-dose Inhaler market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Units), revenue (Million USD), market share and growth rate of Pressurized Metered-dose Inhaler for these regions, from 2012 to 2022 (forecast)
    Europe: Germany, France, UK, Russia, Italy and Benelux;
    Middle East: Saudi Arabia, Israel, UAE and Iran;
    Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Pressurized Metered-dose Inhaler market competition by top manufacturers/players, with Pressurized Metered-dose Inhaler sales volume (K Units), price (USD/Unit), revenue (Million USD) and market share for each manufacturer/player; the top players including
    Glenmark Pharmaceuticals (India)
    Novartis International AG (Switzerland)
    Propeller Health (USA)
    AstraZeneca Plc (Sweden)
    Philips Respironics (Netherlands)
    Teva Pharmaceutical Industries ?Israel?
    Opko Health (USA)
    Merck (USA)
    BioCare Group ?Malaysia?

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into
    Single-dose Inhalers
    Multi-dose Inhalers

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
    Hospitals
    Ambulatory Surgery Centres

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

EMEA (Europe, Middle East and Africa) Pressurized Metered-dose Inhaler Market Report 2017
1 Pressurized Metered-dose Inhaler Overview
    1.1 Product Overview and Scope of Pressurized Metered-dose Inhaler
    1.2 Classification of Pressurized Metered-dose Inhaler
        1.2.1 EMEA Pressurized Metered-dose Inhaler Market Size (Sales) Comparison by Type (2012-2022)
        1.2.2 EMEA Pressurized Metered-dose Inhaler Market Size (Sales) Market Share by Type (Product Category) in 2016
        1.2.3 Single-dose Inhalers
        1.2.4 Multi-dose Inhalers
    1.3 EMEA Pressurized Metered-dose Inhaler Market by Application/End Users
        1.3.1 EMEA Pressurized Metered-dose Inhaler Sales (Volume) and Market Share Comparison by Application (2012-2022
        1.3.2 Hospitals
        1.3.3 Ambulatory Surgery Centres
    1.4 EMEA Pressurized Metered-dose Inhaler Market by Region
        1.4.1 EMEA Pressurized Metered-dose Inhaler Market Size (Value) Comparison by Region (2012-2022)
        1.4.2 Europe Status and Prospect (2012-2022)
        1.4.3 Middle East Status and Prospect (2012-2022)
        1.4.4 Africa Status and Prospect (2012-2022)
    1.5 EMEA Market Size (Value and Volume) of Pressurized Metered-dose Inhaler (2012-2022)
        1.5.1 EMEA Pressurized Metered-dose Inhaler Sales and Growth Rate (2012-2022)
        1.5.2 EMEA Pressurized Metered-dose Inhaler Revenue and Growth Rate (2012-2022)

2 EMEA Pressurized Metered-dose Inhaler Competition by Manufacturers/Players/Suppliers, Region, Type and Application
    2.1 EMEA Pressurized Metered-dose Inhaler Market Competition by Players/Manufacturers
        2.1.1 EMEA Pressurized Metered-dose Inhaler Sales Volume and Market Share of Major Players (2012-2017)
        2.1.2 EMEA Pressurized Metered-dose Inhaler Revenue and Share by Players (2012-2017)
        2.1.3 EMEA Pressurized Metered-dose Inhaler Sale Price by Players (2012-2017)
    2.2 EMEA Pressurized Metered-dose Inhaler (Volume and Value) by Type/Product Category
        2.2.1 EMEA Pressurized Metered-dose Inhaler Sales and Market Share by Type (2012-2017)
        2.2.2 EMEA Pressurized Metered-dose Inhaler Revenue and Market Share by Type (2012-2017)
        2.2.3 EMEA Pressurized Metered-dose Inhaler Sale Price by Type (2012-2017)
    2.3 EMEA Pressurized Metered-dose Inhaler (Volume) by Application
    2.4 EMEA Pressurized Metered-dose Inhaler (Volume and Value) by Region
        2.4.1 EMEA Pressurized Metered-dose Inhaler Sales and Market Share by Region (2012-2017)
        2.4.2 EMEA Pressurized Metered-dose Inhaler Revenue and Market Share by Region (2012-2017)
        2.4.3 EMEA Pressurized Metered-dose Inhaler Sales Price by Region (2012-2017)

3 Europe Pressurized Metered-dose Inhaler (Volume, Value and Sales Price), by Players, Countries, Type and Application
    3.1 Europe Pressurized Metered-dose Inhaler Sales and Value (2012-2017)
        3.1.1 Europe Pressurized Metered-dose Inhaler Sales Volume and Growth Rate (2012-2017)
        3.1.2 Europe Pressurized Metered-dose Inhaler Revenue and Growth Rate (2012-2017)
    3.2 Europe Pressurized Metered-dose Inhaler Sales and Market Share by Type
    3.3 Europe Pressurized Metered-dose Inhaler Sales and Market Share by Application
    3.4 Europe Pressurized Metered-dose Inhaler Sales Volume and Value (Revenue) by Countries
        3.4.1 Europe Pressurized Metered-dose Inhaler Sales Volume by Countries (2012-2017)
        3.4.2 Europe Pressurized Metered-dose Inhaler Revenue by Countries (2012-2017)
        3.4.3 Germany Pressurized Metered-dose Inhaler Sales and Growth Rate (2012-2017)
        3.4.4 France Pressurized Metered-dose Inhaler Sales and Growth Rate (2012-2017)
        3.4.5 UK Pressurized Metered-dose Inhaler Sales and Growth Rate (2012-2017)
        3.4.6 Russia Pressurized Metered-dose Inhaler Sales and Growth Rate (2012-2017)
        3.4.7 Italy Pressurized Metered-dose Inhaler Sales and Growth Rate (2012-2017)
        3.4.8 Benelux Pressurized Metered-dose Inhaler Sales and Growth Rate (2012-2017)

4 Middle East Pressurized Metered-dose Inhaler (Volume, Value and Sales Price), by Region, Type and Application
    4.1 Middle East Pressurized Metered-dose Inhaler Sales and Value (2012-2017)
        4.1.1 Middle East Pressurized Metered-dose Inhaler Sales Volume and Growth Rate (2012-2017)
        4.1.2 Middle East Pressurized Metered-dose Inhaler Revenue and Growth Rate (2012-2017)
    4.2 Middle East Pressurized Metered-dose Inhaler Sales and Market Share by Type
    4.3 Middle East Pressurized Metered-dose Inhaler Sales and Market Share by Application
    4.4 Middle East Pressurized Metered-dose Inhaler Sales Volume and Value (Revenue) by Countries
        4.4.1 Middle East Pressurized Metered-dose Inhaler Sales Volume by Countries (2012-2017)
        4.4.2 Middle East Pressurized Metered-dose Inhaler Revenue by Countries (2012-2017)
        4.4.3 Saudi Arabia Pressurized Metered-dose Inhaler Sales and Growth Rate (2012-2017)
        4.4.4 Israel Pressurized Metered-dose Inhaler Sales and Growth Rate (2012-2017)
        4.4.5 UAE Pressurized Metered-dose Inhaler Sales and Growth Rate (2012-2017)
        4.4.6 Iran Pressurized Metered-dose Inhaler Sales and Growth Rate (2012-2017)

5 Africa Pressurized Metered-dose Inhaler (Volume, Value and Sales Price) by Players, Countries, Type and Application
    5.1 Africa Pressurized Metered-dose Inhaler Sales and Value (2012-2017)
        5.1.1 Africa Pressurized Metered-dose Inhaler Sales Volume and Growth Rate (2012-2017)
        5.1.2 Africa Pressurized Metered-dose Inhaler Revenue and Growth Rate (2012-2017)
    5.2 Africa Pressurized Metered-dose Inhaler Sales and Market Share by Type
    5.3 Africa Pressurized Metered-dose Inhaler Sales and Market Share by Application
    5.4 Africa Pressurized Metered-dose Inhaler Sales Volume and Value (Revenue) by Countries
        5.4.1 Africa Pressurized Metered-dose Inhaler Sales Volume by Countries (2012-2017)
        5.4.2 Africa Pressurized Metered-dose Inhaler Revenue by Countries (2012-2017)
        5.4.3 South Africa Pressurized Metered-dose Inhaler Sales and Growth Rate (2012-2017)
        5.4.4 Nigeria Pressurized Metered-dose Inhaler Sales and Growth Rate (2012-2017)
        5.4.5 Egypt Pressurized Metered-dose Inhaler Sales and Growth Rate (2012-2017)
        5.4.6 Algeria Pressurized Metered-dose Inhaler Sales and Growth Rate (2012-2017)

6 EMEA Pressurized Metered-dose Inhaler Manufacturers/Players Profiles and Sales Data
    6.1 Glenmark Pharmaceuticals (India)
        6.1.1 Company Basic Information, Manufacturing Base and Competitors
        6.1.2 Pressurized Metered-dose Inhaler Product Type, Application and Specification
            6.1.2.1 Product A
            6.1.2.2 Product B
        6.1.3 Glenmark Pharmaceuticals (India) Pressurized Metered-dose Inhaler Sales, Revenue, Price and Gross Margin (2012-2017)
        6.1.4 Main Business/Business Overview
    6.2 Novartis International AG (Switzerland)
        6.2.1 Company Basic Information, Manufacturing Base and Competitors
        6.2.2 Pressurized Metered-dose Inhaler Product Type, Application and Specification
            6.2.2.1 Product A
            6.2.2.2 Product B
        6.2.3 Novartis International AG (Switzerland) Pressurized Metered-dose Inhaler Sales, Revenue, Price and Gross Margin (2012-2017)
        6.2.4 Main Business/Business Overview
    6.3 Propeller Health (USA)
        6.3.1 Company Basic Information, Manufacturing Base and Competitors
        6.3.2 Pressurized Metered-dose Inhaler Product Type, Application and Specification
            6.3.2.1 Product A
            6.3.2.2 Product B
        6.3.3 Propeller Health (USA) Pressurized Metered-dose Inhaler Sales, Revenue, Price and Gross Margin (2012-2017)
        6.3.4 Main Business/Business Overview
    6.4 AstraZeneca Plc (Sweden)
        6.4.1 Company Basic Information, Manufacturing Base and Competitors
        6.4.2 Pressurized Metered-dose Inhaler Product Type, Application and Specification
            6.4.2.1 Product A
            6.4.2.2 Product B
        6.4.3 AstraZeneca Plc (Sweden) Pressurized Metered-dose Inhaler Sales, Revenue, Price and Gross Margin (2012-2017)
        6.4.4 Main Business/Business Overview
    6.5 Philips Respironics (Netherlands)
        6.5.1 Company Basic Information, Manufacturing Base and Competitors
        6.5.2 Pressurized Metered-dose Inhaler Product Type, Application and Specification
            6.5.2.1 Product A
            6.5.2.2 Product B
        6.5.3 Philips Respironics (Netherlands) Pressurized Metered-dose Inhaler Sales, Revenue, Price and Gross Margin (2012-2017)
        6.5.4 Main Business/Business Overview
    6.6 Teva Pharmaceutical Industries ?Israel?
        6.6.1 Company Basic Information, Manufacturing Base and Competitors
        6.6.2 Pressurized Metered-dose Inhaler Product Type, Application and Specification
            6.6.2.1 Product A
            6.6.2.2 Product B
        6.6.3 Teva Pharmaceutical Industries ?Israel? Pressurized Metered-dose Inhaler Sales, Revenue, Price and Gross Margin (2012-2017)
        6.6.4 Main Business/Business Overview
    6.7 Opko Health (USA)
        6.7.1 Company Basic Information, Manufacturing Base and Competitors
        6.7.2 Pressurized Metered-dose Inhaler Product Type, Application and Specification
            6.7.2.1 Product A
            6.7.2.2 Product B
        6.7.3 Opko Health (USA) Pressurized Metered-dose Inhaler Sales, Revenue, Price and Gross Margin (2012-2017)
        6.7.4 Main Business/Business Overview
    6.8 Merck (USA)
        6.8.1 Company Basic Information, Manufacturing Base and Competitors
        6.8.2 Pressurized Metered-dose Inhaler Product Type, Application and Specification
            6.8.2.1 Product A
            6.8.2.2 Product B
        6.8.3 Merck (USA) Pressurized Metered-dose Inhaler Sales, Revenue, Price and Gross Margin (2012-2017)
        6.8.4 Main Business/Business Overview
    6.9 BioCare Group ?Malaysia?
        6.9.1 Company Basic Information, Manufacturing Base and Competitors
        6.9.2 Pressurized Metered-dose Inhaler Product Type, Application and Specification
            6.9.2.1 Product A
            6.9.2.2 Product B
        6.9.3 BioCare Group ?Malaysia? Pressurized Metered-dose Inhaler Sales, Revenue, Price and Gross Margin (2012-2017)
        6.9.4 Main Business/Business Overview

7 Pressurized Metered-dose Inhaler Manufacturing Cost Analysis
    7.1 Pressurized Metered-dose Inhaler Key Raw Materials Analysis
        7.1.1 Key Raw Materials
        7.1.2 Price Trend of Key Raw Materials
        7.1.3 Key Suppliers of Raw Materials
        7.1.4 Market Concentration Rate of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
        7.2.1 Raw Materials
        7.2.2 Labor Cost
        7.2.3 Manufacturing Expenses
    7.3 Manufacturing Process Analysis of Pressurized Metered-dose Inhaler

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
    8.1 Pressurized Metered-dose Inhaler Industrial Chain Analysis
    8.2 Upstream Raw Materials Sourcing
    8.3 Raw Materials Sources of Pressurized Metered-dose Inhaler Major Manufacturers in 2016
    8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
    9.1 Marketing Channel
        9.1.1 Direct Marketing
        9.1.2 Indirect Marketing
        9.1.3 Marketing Channel Development Trend
    9.2 Market Positioning
        9.2.1 Pricing Strategy
        9.2.2 Brand Strategy
        9.2.3 Target Client
    9.3 Distributors/Traders List

10 Market Effect Factors Analysis
    10.1 Technology Progress/Risk
        10.1.1 Substitutes Threat
        10.1.2 Technology Progress in Related Industry
    10.2 Consumer Needs/Customer Preference Change
    10.3 Economic/Political Environmental Change

11 EMEA Pressurized Metered-dose Inhaler Market Forecast (2017-2022)
    11.1 EMEA Pressurized Metered-dose Inhaler Sales, Revenue and Price Forecast (2017-2022)
        11.1.1 EMEA Pressurized Metered-dose Inhaler Sales and Growth Rate Forecast (2017-2022)
        11.1.2 EMEA Pressurized Metered-dose Inhaler Revenue and Growth Rate Forecast (2017-2022)
        11.1.3 EMEA Pressurized Metered-dose Inhaler Price and Trend Forecast (2017-2022)
    11.2 EMEA Pressurized Metered-dose Inhaler Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.3 Europe Pressurized Metered-dose Inhaler Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.4 Middle Eastt Pressurized Metered-dose Inhaler Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.5 Africa Pressurized Metered-dose Inhaler Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.6 EMEA Pressurized Metered-dose Inhaler Sales Forecast by Type (2017-2022)
    11.7 EMEA Pressurized Metered-dose Inhaler Sales Forecast by Application (2017-2022)

12 Research Findings and Conclusion

13 Appendix
    13.1 Methodology/Research Approach
        13.1.1 Research Programs/Design
        13.1.2 Market Size Estimation
        13.1.3 Market Breakdown and Data Triangulation
    13.2 Data Source
        13.2.1 Secondary Sources
        13.2.2 Primary Sources
    13.3 Disclaimer